Fuzzy Decision of Drug Dosage for Type-1 Human Immunodeficiency Virus Infected Patients

被引:0
作者
Fu, Na [1 ,2 ]
Zhang, Wenjie [1 ]
Xie, Xiangpeng [3 ]
机构
[1] Jiangsu Univ, Affiliated Hosp, Zhenjiang 212001, Jiangsu, Peoples R China
[2] Jiangsu Univ, Sch Med, Zhenjiang 212013, Jiangsu, Peoples R China
[3] Nanjing Univ Posts & Telecommun, Inst Adv Technol, Nanjing 210023, Jiangsu, Peoples R China
来源
PROCEEDINGS OF 2018 5TH IEEE INTERNATIONAL CONFERENCE ON CLOUD COMPUTING AND INTELLIGENCE SYSTEMS (CCIS) | 2018年
关键词
Drug dosage; Fuzzy decision; Human inununodeficiency virus; Clinical care; POPULATION-DYNAMICS; MODEL; HIV; SYSTEMS;
D O I
暂无
中图分类号
TM [电工技术]; TN [电子技术、通信技术];
学科分类号
0808 ; 0809 ;
摘要
The research subject of fuzzy decision of drug dosage for type-1 human immunodeficiency virus(HIV-1) infected patients is discussed by the aid of a existing fuzzy dynamic HIV-1 model. Firstly, by making use of the previous fuzzy modeling method, that intractable nonlinear predator-prey like model is converted to a set of tractable linear sub-models. Then, based on the above tractable sub-models and a kind of sampled-data fuzzy control strategy with a set of decay factors, all the dynamic properties of the fuzzy dynamic HIV-1 model can be acquired by means of high-performance computer simulations. Thirdly, some fuzzy decisions of drug dosage for HIV-1 infected patients are reasoned by consulting the computer simulation results and thus a bank of instructional advices are suggested for clinic care. Finally, some conclusions and future study directions are specifically discussed in the conclusion part.
引用
收藏
页码:163 / 166
页数:4
相关论文
共 50 条
  • [1] Prevalence of Hepatitis C Virus and Human Pegivirus Type 1 Co-Infection in Patients Infected with Human Immunodeficiency Virus Type-1
    Elahimanesh, Zahra
    Bokharaei-Salim, Farah
    Donyavi, Tahereh
    Monavari, Seyed Hamidreza
    Tavakoli, Ahmad
    Khoshmirsafa, Majid
    Chavoshpour, Sara
    Abbasi-Kolli, Mohammad
    Ghalejoogh, Zohreh Yousefi
    Kiani, Seyed Jalal
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2024, 30 (03): : 53 - 58
  • [2] A general framework for multi-compartmental analysis of drug chemotherapy dynamics in human immunodeficiency virus type-1 infected individuals
    Joly, Marcel
    Pinto, Jose M.
    APPLIED MATHEMATICAL MODELLING, 2012, 36 (12) : 5830 - 5843
  • [3] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 TROPISM FOR HUMAN MACROPHAGES
    COLLMAN, R
    PATHOBIOLOGY, 1992, 60 (04) : 213 - 218
  • [4] Genomic diversity of human immunodeficiency virus type-1 in India
    Sahni, AK
    Prasad, VVSP
    Seth, P
    INTERNATIONAL JOURNAL OF STD & AIDS, 2002, 13 (02) : 115 - 118
  • [5] INACTIVATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY ALCOHOLS
    VANBUEREN, J
    LARKIN, DP
    SIMPSON, RA
    JOURNAL OF HOSPITAL INFECTION, 1994, 28 (02) : 137 - 148
  • [6] AGGREGATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY HUMAN SALIVARY SECRETIONS
    BERGEY, EJ
    CHO, MI
    HAMMARSKJOLD, ML
    REKOSH, D
    LEVINE, MJ
    BLUMBERG, BM
    EPSTEIN, LG
    CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (3-4) : 467 - 474
  • [7] Drug Resistance in Human Immunodeficiency Virus Type-1 Infected Zambian Children Using Adult Fixed Dose Combination Stavudine, Lamivudine, and Nevirapine
    Gupta, Ravindra K.
    Ford, Deborah
    Mulenga, Veronica
    Walker, A. Sarah
    Kabamba, Desire
    Kalumbi, Moxmalama
    Grant, Paul R.
    Ferrier, Alexander
    Pillay, Deenan
    Gibb, Diana M.
    Chintu, Chifumbe
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (08) : E57 - E62
  • [8] Different sensitivity to apoptosis in cells of monocytic or lymphocytic origin chronically infected with human immunodeficiency virus type-1
    Pinti, M
    Biswas, P
    Troiano, L
    Nasi, M
    Ferraresi, R
    Mussini, C
    Vecchiet, J
    Esposito, R
    Paganelli, R
    Cossarizza, A
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2003, 228 (11) : 1346 - 1354
  • [9] Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis
    Biru, T.
    Lennemann, T.
    Stuermer, M.
    Stephan, C.
    Nisius, G.
    Cinatl, J.
    Staszewski, S.
    Guertler, L. G.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2010, 199 (04) : 323 - 332
  • [10] Prognostic Value of the Fibrosis-4 Index in Human Immunodeficiency Virus Type-1 Infected Patients Initiating Antiretroviral Therapy with or without Hepatitis C Virus
    Mussini, Cristina
    Lorenzini, Patrizia
    Puoti, Massimo
    Lichtner, Miriam
    Lapadula, Giuseppe
    Di Giambenedetto, Simona
    Antinori, Andrea
    Madeddu, Giordano
    Cozzi-Lepri, Alessandro
    Monforte, Antonella d'Arminio
    De Luca, Andrea
    PLOS ONE, 2015, 10 (12):